Marketers disregard online behaviors

Share this article:
Pharmaceutical marketers leave their own online behaviors at the office door when it comes to marketing their brands, a new survey found.

“When you look at the difference between what pharmaceutical marketers say are important in their budgets and you ask them what they use in their personal life, there’s an almost two-to-one relevance gap,” said Bruce Grant, SVP, strategy and development at MBC.

He made his remarks while presenting highlights from MBC’s “The Shift to On-Demand Pharmaceutical Marketing—2007 eMarketing Survey.

The survey was conducted in conjunction with The Center for Business Intelligence and unveiled at CBI’s e-marketing conference last month.

“When we asked (marketers) what services they provide to health care providers, not even half of the respondents said they provide a Web site,” Grant said. “Almost as many said ‘we don’t’ or ‘we have no plan’ to provide a Web site for HCPs.”

Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Channel

Email Newsletters

MM&M Future Leaders

Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...